CH496709A - Verfahren zur Herstellung von 2-Hydroxyniederalkyl-4 bzw. 5-nitroimidazolen - Google Patents

Verfahren zur Herstellung von 2-Hydroxyniederalkyl-4 bzw. 5-nitroimidazolen

Info

Publication number
CH496709A
CH496709A CH10768A CH10768A CH496709A CH 496709 A CH496709 A CH 496709A CH 10768 A CH10768 A CH 10768A CH 10768 A CH10768 A CH 10768A CH 496709 A CH496709 A CH 496709A
Authority
CH
Switzerland
Prior art keywords
nitroimidazoles
hydroxy
preparation
lower alkyl
alkyl
Prior art date
Application number
CH10768A
Other languages
German (de)
English (en)
Inventor
Kollonitsch Janos
Scott Alan Newton
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH496709A publication Critical patent/CH496709A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/93Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by halogen atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/94Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH10768A 1967-01-06 1968-01-05 Verfahren zur Herstellung von 2-Hydroxyniederalkyl-4 bzw. 5-nitroimidazolen CH496709A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60764267A 1967-01-06 1967-01-06

Publications (1)

Publication Number Publication Date
CH496709A true CH496709A (de) 1970-09-30

Family

ID=24433101

Family Applications (1)

Application Number Title Priority Date Filing Date
CH10768A CH496709A (de) 1967-01-06 1968-01-05 Verfahren zur Herstellung von 2-Hydroxyniederalkyl-4 bzw. 5-nitroimidazolen

Country Status (4)

Country Link
CH (1) CH496709A (fr)
FR (1) FR1588786A (fr)
GB (2) GB1201269A (fr)
NL (1) NL6717043A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2827351A1 (de) * 1978-06-22 1980-01-10 Basf Ag 2-substituierte 1-alykl-nitroimidazole und verfahren zur herstellung von 2-substituierten 1-alkyl-nitroimidazolen
US4728664A (en) * 1985-08-28 1988-03-01 Merck & Co., Inc. Uniquely non-mutagenic substituted nitroimidazole

Also Published As

Publication number Publication date
FR1588786A (fr) 1970-03-16
GB1201269A (en) 1970-08-05
NL6717043A (fr) 1968-07-08
GB1201270A (en) 1970-08-05

Similar Documents

Publication Publication Date Title
CH505118A (de) Verfahren zur Herstellung von 1,2,4-Triazin-5-onen
CH481110A (de) Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
CH473841A (de) Verfahren zur Herstellung von Hydroxy- bzw. Dihydroxyalkyldextranverbindungen
CH489510A (de) Verfahren zur Herstellung von substituierten v-Triazolen
CH498142A (de) Verfahren zur Herstellung von substituierten Piperidino-alkylthianaphthenen und -benzofuranen
CH503674A (de) Verfahren zur Herstellung von 4-Halogen-2-tert.butoxybutanen
CH532026A (de) Verfahren zur Herstellung von 8-Nitro-2-acyl bzw. 2-Azinyl-aminonaphthalinsulfonsäuren
CH509330A (de) Verfahren zur Herstellung von 5-Phenyl-1H-1,5-benzo-diazepin-2,4-dionen
CH526524A (de) Verfahren zur Herstellung von 6a,6B-Difluorsteroiden
CH505096A (de) Verfahren zur Herstellung von substituierten p-Hydroxyphenylhydrazonen
CH507930A (de) Verfahren zur Herstellung von 5-Methyl-4-hydroxy-2,3-dihydrofuran-3-on
AT293392B (de) Verfahren zur Herstellung von Benzodiazepinen bzw. von Salzen hievon
CH527828A (de) Verfahren zur Herstellung von 2,4-Benzdiazepinen
AT277270B (de) Verfahren zur Herstellung von substituierten 2-Mercapto-4,6-dichlor-s-triazinen
CH508640A (de) Verfahren zur Herstellung von 2,4-Bis-alkylamino-6-chlor-s-triazinen
CH496709A (de) Verfahren zur Herstellung von 2-Hydroxyniederalkyl-4 bzw. 5-nitroimidazolen
CH508667A (de) Verfahren zur Herstellung von 2-Bisdiestern von Phosphonomethylamino-1,3-dihydroxypropan
CH479567A (de) Verfahren zur Herstellung von Androst- bzw. Östr-4-en-17B-yloxy-trialkylsilanen
CH490416A (de) Verfahren zur Herstellung von 3-Amino-2-imino-4-(5-nitro-2-furyl)- 4-thiazolin bzw. seinen Salzen
AT281318B (de) Verfahren zur Herstellung von 3,5-Dioxo-4,5-seco-13β-R-17α-äthinyl-17β-hydroxygona-9-enen
CH503008A (de) Verfahren zur Herstellung von 17 -Acyloxy-bzw. 17a-Hydroxy-11B-methyl-19-nor-pregn-4-en-3,20-dionen
CH533093A (de) Verfahren zur Herstellung von 17B-Hydroxy-15B,16B-methylen-4-androsten-3-on
CH504454A (de) Verfahren zur Herstellung von 3-Imino-1,2-benzisothiazolinen
CH506526A (de) Verfahren zur Herstellung von 4-Phenylimino-1,4-Dihydrochinolinen
CH489483A (de) Verfahren zur Herstellung von 3-Enolacylaten von 4-Androstenen bzw. 19-Nor-4-androstenen

Legal Events

Date Code Title Description
PL Patent ceased